International Training Network for Healthcare Performance Intelligence Professionals

Testimonials

Newsletter subscription

Panel discussion

Selected publications:

Corvinus logo petra baji small2 400x412lgulacs

Click on the title to go to PubMed

- Access to biologicals in Crohn's disease in ten European countries.

- Cost-effectiveness of biological treatment sequences for fistulising Crohn's disease across Europe.

- The Rituximab Biosimilar CT-P10 in Rheumatology and Cancer: A Budget Impact Analysis in 28 European Countries.

- Perceived Risks Contra Benefits of Using Biosimilar Drugs in Ulcerative Colitis: Discrete Choice Experiment among Gastroenterologists.

- Treatment preferences of originator versus biosimilar drugs in Crohn's disease; discrete choice experiment among gastroenterologists

- Comparative analysis of decision maker preferences for equity/efficiency attributes in reimbursement decisions in three European countries.in reimbursement decisions in three European countries.

- Preferences of Hungarian consumers for quality, access and price attributes of health care services.

- Quality management and patient safety: survey results from 102 Hungarian hospitalsQuality management and patient safety: survey results from 102 Hungarian hospitals

This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 765141. This website reflects only the author's view and the European Commission is not responsible for any use that may be made of the information it contains

© 2020 FavThemes